Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy
About half of cancer patients (50%) receive radiotherapy (RT) for the treatment of local tumors. However, one of the main obstacles in RT is the close proximity of adjacent organs at risk, resulting in treatment doses being limited by significant tissue toxicity, hence preventing the necessary dose...
Main Authors: | Abdulaziz Alhussan, Ece Pinar Demirci Bozdoğan, Devika B. Chithrani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/4/442 |
Similar Items
-
In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer
by: Abdulaziz Alhussan, et al.
Published: (2024-05-01) -
Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics
by: Nolan Jackson, et al.
Published: (2023-09-01) -
Utilizing two-dimensional monolayer and three-dimensional spheroids to enhance radiotherapeutic potential by combining gold nanoparticles and docetaxel
by: Kyle Bromma, et al.
Published: (2023-10-01) -
Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin
by: Ocean Han, et al.
Published: (2022-01-01) -
Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy
by: Chen Y, et al.
Published: (2023-04-01)